{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-007317","form_type":"8-K/A","ticker":"IMMX","cik":"0001873835","company_name":"Immix Biopharma, Inc.","filed_at":"2023-03-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.300665+00:00","generated_at":"2026-06-18T04:56:12.698170+00:00","sec_items":["1.01","7.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Immix Biopharma amends 8-K to clarify no deposits at Silvergate or Silicon Valley Bank","bullets":["Filing corrects original 8-K's item number from 1.01 to 7.01 for Regulation FD disclosure.","Company confirms neither Immix nor its subsidiaries hold cash deposits or securities at Silvergate Bank or Silicon Valley Bank.","Disclosure addresses investor concerns during the March 2023 regional banking crisis."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-007317","json":"https://secwatch.observer/filing/0001493152-23-007317.json","markdown":"https://secwatch.observer/filing/0001493152-23-007317.md","text":"https://secwatch.observer/filing/0001493152-23-007317.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/0001493152-23-007317-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1873835/000149315223007317/form8-ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T04:56:12.698170+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}